On Thursday (July 25), England-based tobacco company Imperial Brands (LSE:IMB,OTCQX:IMBBF) added to its marijuana exposure thanks to a new C$123 million investment in Auxly Cannabis Group (TSXV:XLY,OTCQX:CBWTF).

Imperial will obtain a 19.9 percent stake in the company since the deal is structured as debenture. The price per share was set at C$0.81 for the transaction, which represents an 11 percent premium for Auxly’s closing price on Wednesday (July 24).


“Auxly’s unique assets and capabilities, including strong science and product development credentials, make it an ideal partner for Imperial in the legal Canadian cannabis market,” Matthew Phillips, Imperial’s chief development officer, said in a press release.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

The transaction will be set in a three year term with a fixed annual interest rate of 4 percent. With this investment, Imperial also secured itself one of the five director seats in the Auxly board.

Auxly operates as a cannabis investment firm looking for partnerships in the space to add to its portfolio. The company is an active investment participant in nine cannabis cultivation operations in Canada.

Shares of the Canadian cannabis company rocketed over 20 percent in value following confirmation of the investment deal at the opening bell. Auxly shares closed at a price of C$0.91 on Thursday, representing a boost of 24.66 percent in value.

Auxly also holds strategic investments with publicly traded Dixie Brands (CSE:DIXI.U,OTCQX:DXBRF) and Spiritleaf, the retail division of Inner Spirit Holdings (CSE:ISH).

Chuck Rifici, chairman and CEO of Auxly, said in a press release that his company had been selected after Imperial completed an evaluation of the Canadian cannabis market.

As part of the deal, Auxly will gain immediate access to licenses for Imperial’s lineup of vape technology through subsidiary Nerudia.

According to Auxly, the cannabis firm will gain exclusivity with Imperial as the only partner for the entire development cycle for all types of cannabis products across the world.

“We are particularly excited to partner with Imperial Brands on current and future intellectual property and product development,” Rifici said.

Nerudia is a vaporizer developer working on the design and production of next generation vaping products.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Cannabis edibles and extracts are set to become legal in Canada starting on October 17. Health Canada, the regulatory body overseeing the marijuana industry, estimates these products will hit the market for sale sometime in mid-December.

In response to the collaboration for vaporizer technology, Imperial further explained: “The shared ability to rapidly innovate as the Canadian market evolves is key to future growth and Auxly will work closely with a small dedicated team from Nerudia in developing a portfolio of new and enhanced brands and products.”

This deal isn’t the first time Imperial has invested in the marijuana industry in some capacity. In June 2018, Imperial gained a stake in British biotech research company Oxford Cannabinoid Technologies.

Before the investment announcement was made, Auxly’s shares slumped throughout 2019, dropping 23.96 percent in value.

Similarly, the British tobacco company hasn’t fared all too well in the trading market, taking in a decline of 10.35 percent in 2019 as of Wednesday’s close.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Inner Spirit Holdings is a client of the Investing News Network. This article is not paid-for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Cannabis research firm New Frontier Data has released a new report in which it projects that the value of the total cannabis industry will reach US$51 billion by the year 2025.

Also this week, a few cannabis companies announced new international ventures. This side of the space is full of potential, but is relatively new compared to markets like the US and Canada.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“the Company”) today announced that it has officially launched its new cold storage services for 3rd party manufacturers with the onboarding of its first client, Kase Manufacturing (‘Kase’).

Kase will rent portions of TransCanna‘s 4,400 square foot, state-of-the-art cold storage cannabis freezer for specialized storage of Kase’s fresh-frozen cannabis biomass. The sub-40 degree Fahrenheit cannabis freezer, roughly the size of a five bedroom house, is the largest of its kind in Northern California.

Keep reading... Show less

Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”), an established Canadian cannabis and vape retailer, is pleased to announce that further to its press release dated August 26, 2021, all of its issued and outstanding common shares (the “Common Shares”) will begin trading on a post-consolidation basis on September 17, 2021 at the commencement of trading on the TSX Venture Exchange (“TSXV”).

On August 26, 2021, the Company announced that the Common Shares would be consolidated on the basis of one (1) post-consolidation Common Share for each five (5) pre-consolidation Common Shares (the “Share Consolidation“).

Keep reading... Show less

 TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it has received pre-qualification approval for cultivation, processing and retail licenses from the state of Michigan’s Marijuana Regulatory Agency pursuant to the Medical Marihuana Facilities Licensing Act. The pre-qualification approval represents TerrAscend’s successful completion of the most comprehensive portion of the State’s licensing and regulatory approval process. The pre-qualification approval is a key closing condition for TerrAscend’s previously announced acquisition of Gage Growth Corp.(“Gage”) (the “Transaction”). The Transaction will close as soon as possible after receipt of the applicable shareholder, court and other regulatory approvals and satisfaction or waiver of all other conditions in the definitive arrangement agreement (the “Arrangement Agreement”).

Keep reading... Show less

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce it has increased the size of its previously announced non-brokered private placement from USD $2,000,000 to over USD $2,500,000 (the “Private Placement”). This increase is designed to accommodate additional demand that the Company has received in the financing.

Keep reading... Show less